/**
 * Neuro-Epi — Reporting Guidelines Hub
 * Interactive checklists for major research reporting guidelines (CONSORT, STROBE, PRISMA, etc.)
 */
(function() {
    'use strict';
    const MODULE_ID = 'reporting-guidelines';

    var currentGuideline = 'CONSORT';
    var checklistState = {};

    /* ------------------------------------------------------------------ */
    /*  Guideline metadata                                                 */
    /* ------------------------------------------------------------------ */
    var guidelines = {
        'CONSORT':   { name: 'CONSORT 2010',     use: 'Randomised controlled trials' },
        'STROBE':    { name: 'STROBE',            use: 'Observational studies (cohort, case-control, cross-sectional)' },
        'PRISMA':    { name: 'PRISMA 2020',       use: 'Systematic reviews and meta-analyses' },
        'PRISMA-ScR':{ name: 'PRISMA-ScR',        use: 'Scoping reviews' },
        'SPIRIT':    { name: 'SPIRIT 2013',       use: 'Clinical trial protocols' },
        'STARD':     { name: 'STARD 2015',        use: 'Diagnostic accuracy studies' },
        'TRIPOD':    { name: 'TRIPOD',            use: 'Prediction model studies' },
        'CARE':      { name: 'CARE',              use: 'Case reports' },
        'CHEERS':    { name: 'CHEERS 2022',       use: 'Health economic evaluations' },
        'ARRIVE':    { name: 'ARRIVE 2.0',        use: 'Animal research' },
        'AGREE-II':  { name: 'AGREE II',          use: 'Clinical practice guidelines appraisal' },
        'RECORD':    { name: 'RECORD',            use: 'Studies using routinely collected health data' },
        'MOOSE':     { name: 'MOOSE',             use: 'Meta-analyses of observational studies' }
    };

    /* ------------------------------------------------------------------ */
    /*  Full checklists                                                    */
    /* ------------------------------------------------------------------ */
    var checklists = {};

    checklists['CONSORT'] = [
        { num: '1a', section: 'Title / Abstract', text: 'Identification as a randomised trial in the title' },
        { num: '1b', section: 'Title / Abstract', text: 'Structured summary of trial design, methods, results, and conclusions' },
        { num: '2a', section: 'Introduction', text: 'Scientific background and explanation of rationale' },
        { num: '2b', section: 'Introduction', text: 'Specific objectives or hypotheses' },
        { num: '3a', section: 'Methods', text: 'Description of trial design (e.g., parallel, factorial) including allocation ratio' },
        { num: '3b', section: 'Methods', text: 'Important changes to methods after trial commencement with reasons' },
        { num: '4a', section: 'Methods', text: 'Eligibility criteria for participants' },
        { num: '4b', section: 'Methods', text: 'Settings and locations where the data were collected' },
        { num: '5',  section: 'Methods', text: 'Interventions for each group with sufficient details to allow replication, including how and when administered' },
        { num: '6a', section: 'Methods', text: 'Completely defined pre-specified primary and secondary outcome measures, including how and when assessed' },
        { num: '6b', section: 'Methods', text: 'Any changes to trial outcomes after the trial commenced, with reasons' },
        { num: '7a', section: 'Methods', text: 'How sample size was determined' },
        { num: '7b', section: 'Methods', text: 'When applicable, explanation of any interim analyses and stopping guidelines' },
        { num: '8a', section: 'Methods', text: 'Method used to generate the random allocation sequence' },
        { num: '8b', section: 'Methods', text: 'Type of randomisation; details of any restriction (e.g., blocking and block size)' },
        { num: '9',  section: 'Methods', text: 'Mechanism used to implement the random allocation sequence, describing any steps to conceal the sequence' },
        { num: '10', section: 'Methods', text: 'Who generated the random allocation sequence, enrolled participants, and assigned participants to interventions' },
        { num: '11a', section: 'Methods', text: 'If done, who was blinded after assignment to interventions and how' },
        { num: '11b', section: 'Methods', text: 'If relevant, description of the similarity of interventions' },
        { num: '12a', section: 'Methods', text: 'Statistical methods used to compare groups for primary and secondary outcomes' },
        { num: '12b', section: 'Methods', text: 'Methods for additional analyses, such as subgroup analyses and adjusted analyses' },
        { num: '13a', section: 'Results', text: 'For each group, the numbers of participants randomly assigned, receiving intended treatment, and analysed for the primary outcome' },
        { num: '13b', section: 'Results', text: 'For each group, losses and exclusions after randomisation, together with reasons' },
        { num: '14a', section: 'Results', text: 'Dates defining the periods of recruitment and follow-up' },
        { num: '14b', section: 'Results', text: 'Why the trial ended or was stopped' },
        { num: '15', section: 'Results', text: 'A table showing baseline demographic and clinical characteristics for each group' },
        { num: '16', section: 'Results', text: 'For each group, number of participants (denominator) included in each analysis and whether the analysis was by original assigned groups' },
        { num: '17a', section: 'Results', text: 'For each primary and secondary outcome, results for each group, estimated effect size and its precision (e.g., 95% CI)' },
        { num: '17b', section: 'Results', text: 'For binary outcomes, presentation of both absolute and relative effect sizes is recommended' },
        { num: '18', section: 'Results', text: 'Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing pre-specified from exploratory' },
        { num: '19', section: 'Results', text: 'All important harms or unintended effects in each group' },
        { num: '20', section: 'Discussion', text: 'Trial limitations, addressing sources of potential bias, imprecision, and multiplicity of analyses' },
        { num: '21', section: 'Discussion', text: 'Generalisability (external validity, applicability) of the trial findings' },
        { num: '22', section: 'Discussion', text: 'Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence' },
        { num: '23', section: 'Other', text: 'Registration number and name of trial registry' },
        { num: '24', section: 'Other', text: 'Where the full trial protocol can be accessed, if available' },
        { num: '25', section: 'Other', text: 'Sources of funding and other support, role of funders' }
    ];

    checklists['STROBE'] = [
        { num: '1',  section: 'Title / Abstract', text: 'Indicate the study design with a commonly used term in the title or abstract; provide an informative and balanced summary' },
        { num: '2',  section: 'Introduction', text: 'Explain the scientific background and rationale for the investigation being reported' },
        { num: '3',  section: 'Introduction', text: 'State specific objectives, including any prespecified hypotheses' },
        { num: '4',  section: 'Methods', text: 'Present key elements of study design early in the paper' },
        { num: '5',  section: 'Methods', text: 'Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection' },
        { num: '6a', section: 'Methods', text: 'Cohort: Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up' },
        { num: '6b', section: 'Methods', text: 'Case-control: Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls' },
        { num: '6c', section: 'Methods', text: 'Cross-sectional: Give the eligibility criteria, and the sources and methods of selection of participants' },
        { num: '7',  section: 'Methods', text: 'Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable' },
        { num: '8',  section: 'Methods', text: 'For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group' },
        { num: '9',  section: 'Methods', text: 'Describe any efforts to address potential sources of bias' },
        { num: '10', section: 'Methods', text: 'Explain how the study size was arrived at' },
        { num: '11', section: 'Methods', text: 'Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why' },
        { num: '12a', section: 'Methods', text: 'Describe all statistical methods, including those used to control for confounding' },
        { num: '12b', section: 'Methods', text: 'Describe any methods used to examine subgroups and interactions' },
        { num: '12c', section: 'Methods', text: 'Explain how missing data were addressed' },
        { num: '12d', section: 'Methods', text: 'Cohort: If applicable, explain how loss to follow-up was addressed; Case-control: If applicable, explain how matching of cases and controls was addressed; Cross-sectional: If applicable, describe analytical methods taking account of sampling strategy' },
        { num: '12e', section: 'Methods', text: 'Describe any sensitivity analyses' },
        { num: '13a', section: 'Results', text: 'Report numbers of individuals at each stage of study (e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed)' },
        { num: '13b', section: 'Results', text: 'Give reasons for non-participation at each stage' },
        { num: '13c', section: 'Results', text: 'Consider use of a flow diagram' },
        { num: '14a', section: 'Results', text: 'Give characteristics of study participants and information on exposures and potential confounders' },
        { num: '14b', section: 'Results', text: 'Indicate number of participants with missing data for each variable of interest' },
        { num: '14c', section: 'Results', text: 'Cohort: Summarise follow-up time (e.g., average and total amount)' },
        { num: '15', section: 'Results', text: 'Cohort: Report numbers of outcome events or summary measures over time; Case-control: Report numbers in each exposure category, or summary measures of exposure; Cross-sectional: Report numbers of outcome events or summary measures' },
        { num: '16a', section: 'Results', text: 'Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision. Make clear which confounders were adjusted for and why' },
        { num: '16b', section: 'Results', text: 'Report category boundaries when continuous variables were categorized' },
        { num: '16c', section: 'Results', text: 'If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period' },
        { num: '17', section: 'Results', text: 'Report other analyses done (e.g., analyses of subgroups and interactions, and sensitivity analyses)' },
        { num: '18', section: 'Discussion', text: 'Summarise key results with reference to study objectives' },
        { num: '19', section: 'Discussion', text: 'Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss direction and magnitude of any potential bias' },
        { num: '20', section: 'Discussion', text: 'Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence' },
        { num: '21', section: 'Discussion', text: 'Discuss the generalisability (external validity) of the study results' },
        { num: '22', section: 'Other', text: 'Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based' }
    ];

    checklists['PRISMA'] = [
        { num: '1',  section: 'Title', text: 'Identify the report as a systematic review, meta-analysis, or both' },
        { num: '2',  section: 'Abstract', text: 'Provide a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications' },
        { num: '3',  section: 'Introduction', text: 'Describe the rationale for the review in the context of existing knowledge' },
        { num: '4',  section: 'Introduction', text: 'Provide an explicit statement of the review question(s) using PICO or similar framework' },
        { num: '5',  section: 'Methods', text: 'Indicate whether a review protocol exists, where it can be accessed, and if available provide registration information' },
        { num: '6',  section: 'Methods', text: 'Specify eligibility criteria including study characteristics and report characteristics used as criteria for including and excluding studies' },
        { num: '7',  section: 'Methods', text: 'Describe all information sources (databases, registers, websites, organisations, reference lists) and date last searched' },
        { num: '8',  section: 'Methods', text: 'Present the full search strategies for all databases, registers, and websites, including any filters and limits used' },
        { num: '9',  section: 'Methods', text: 'State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and if applicable included in meta-analysis)' },
        { num: '10', section: 'Methods', text: 'Describe method of data extraction from reports and any processes for obtaining and confirming data from investigators' },
        { num: '11', section: 'Methods', text: 'List and define all variables for which data were sought and any assumptions and simplifications made' },
        { num: '12', section: 'Methods', text: 'Describe methods used for assessing risk of bias of individual studies and how this information is to be used in data synthesis' },
        { num: '13', section: 'Methods', text: 'State the principal summary measures (e.g., risk ratio, difference in means)' },
        { num: '14', section: 'Methods', text: 'Describe the methods of handling data and combining results of studies including measures of consistency (e.g., I2) for each meta-analysis' },
        { num: '15', section: 'Methods', text: 'Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting)' },
        { num: '16', section: 'Methods', text: 'Describe methods of additional analyses (sensitivity, subgroup, meta-regression), if done, indicating which were pre-specified' },
        { num: '17', section: 'Results', text: 'Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram' },
        { num: '18', section: 'Results', text: 'For each study, present characteristics for which data were extracted and provide the citations' },
        { num: '19', section: 'Results', text: 'Present data on risk of bias of each study and, if available, any outcome-level assessment' },
        { num: '20', section: 'Results', text: 'For all outcomes considered (benefits or harms), present for each study simple summary data, effect estimates and confidence intervals' },
        { num: '21', section: 'Results', text: 'Present results of each meta-analysis done, including confidence intervals and measures of consistency' },
        { num: '22', section: 'Results', text: 'Present results of any assessment of risk of bias across studies' },
        { num: '23', section: 'Results', text: 'Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression)' },
        { num: '24', section: 'Discussion', text: 'Summarise the main findings including the strength of evidence for each main outcome; consider their relevance to key groups' },
        { num: '25', section: 'Discussion', text: 'Discuss limitations at study and outcome level (e.g., risk of bias) and at review level (e.g., incomplete retrieval, reporting bias)' },
        { num: '26', section: 'Discussion', text: 'Provide a general interpretation of the results in the context of other evidence and implications for future research' },
        { num: '27', section: 'Funding', text: 'Describe sources of funding for the systematic review and other support; role of funders' }
    ];

    checklists['PRISMA-ScR'] = [
        { num: '1',  section: 'Title', text: 'Identify the report as a scoping review' },
        { num: '2',  section: 'Abstract', text: 'Provide a structured summary with objectives, eligibility criteria, sources, charting methods, results, and conclusions' },
        { num: '3',  section: 'Introduction', text: 'Describe the rationale for the scoping review in the context of what is already known' },
        { num: '4',  section: 'Introduction', text: 'Provide an explicit statement of the questions the scoping review addresses (PCC framework)' },
        { num: '5',  section: 'Methods', text: 'Indicate if a scoping review protocol exists and where it can be accessed; state if and where it was registered' },
        { num: '6',  section: 'Methods', text: 'Specify characteristics of the sources of evidence used as eligibility criteria and their rationale' },
        { num: '7',  section: 'Methods', text: 'Describe all information sources and the date last searched' },
        { num: '8',  section: 'Methods', text: 'Present the full search strategy for at least one database including limits used' },
        { num: '9',  section: 'Methods', text: 'State the process for selecting sources of evidence (screening, eligibility)' },
        { num: '10', section: 'Methods', text: 'Describe the methods of charting data from the included sources' },
        { num: '11', section: 'Methods', text: 'List and define all variables for which data were sought and charted' },
        { num: '12', section: 'Methods', text: 'If done, provide the rationale for conducting a critical appraisal; describe the method used' },
        { num: '13', section: 'Methods', text: 'Describe methods of handling and summarizing the data that were charted' },
        { num: '14', section: 'Results', text: 'Give numbers of sources of evidence screened, assessed for eligibility, and included, with reasons for exclusions at each stage' },
        { num: '15', section: 'Results', text: 'Present characteristics of sources of evidence' },
        { num: '16', section: 'Results', text: 'If done, present the critical appraisal results' },
        { num: '17', section: 'Results', text: 'For each included source, present the relevant data that were charted relating to the review questions' },
        { num: '18', section: 'Results', text: 'Present main results (including summary/synthesis of charted data) that relate to the review questions and objectives' },
        { num: '19', section: 'Discussion', text: 'Summarise the main findings, relating them to the review questions and objectives' },
        { num: '20', section: 'Discussion', text: 'Discuss the limitations of the scoping review process' },
        { num: '21', section: 'Discussion', text: 'Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications' },
        { num: '22', section: 'Funding', text: 'Describe sources of funding for the included sources of evidence and for the scoping review; role of funders' }
    ];

    checklists['SPIRIT'] = [
        { num: '1',  section: 'Admin', text: 'Descriptive title identifying the study design, population, interventions, and if applicable, trial acronym' },
        { num: '2a', section: 'Admin', text: 'Trial registration number and registry name; for prospectively registered trials, date of registration' },
        { num: '2b', section: 'Admin', text: 'All items from the WHO Trial Registration Data Set' },
        { num: '3',  section: 'Admin', text: 'Protocol version number, date, and amendment history' },
        { num: '4',  section: 'Admin', text: 'Sources and types of financial, material, and other support' },
        { num: '5a', section: 'Admin', text: 'Names, institutional affiliations, and roles of protocol contributors' },
        { num: '5b', section: 'Admin', text: 'Name and contact information for the trial sponsor' },
        { num: '5c', section: 'Admin', text: 'Role of study sponsor and funders in study design, collection, management, analysis, interpretation, report writing, and publication decisions' },
        { num: '5d', section: 'Admin', text: 'Composition, roles, and responsibilities of the coordinating centre, steering committee, endpoint adjudication committee, data management team, and others' },
        { num: '6a', section: 'Introduction', text: 'Description of research question and justification for undertaking the trial, including summary of relevant studies' },
        { num: '6b', section: 'Introduction', text: 'Explanation for choice of comparators' },
        { num: '7',  section: 'Introduction', text: 'Specific objectives or hypotheses' },
        { num: '8',  section: 'Methods', text: 'Description of trial design including type of trial, allocation ratio, and framework (superiority, equivalence, noninferiority, exploratory)' },
        { num: '9',  section: 'Methods', text: 'Description of study settings and list of countries where data will be collected' },
        { num: '10', section: 'Methods', text: 'Eligibility criteria for participants: inclusion and exclusion criteria' },
        { num: '11a', section: 'Methods', text: 'Interventions for each group with sufficient detail to allow replication' },
        { num: '11b', section: 'Methods', text: 'Criteria for discontinuing or modifying allocated interventions' },
        { num: '11c', section: 'Methods', text: 'Strategies to improve adherence and procedures for monitoring adherence' },
        { num: '11d', section: 'Methods', text: 'Relevant concomitant care and interventions permitted or prohibited during the trial' },
        { num: '12', section: 'Methods', text: 'Primary, secondary, and other outcomes including the specific measurement variable, analysis metric, method of aggregation, and time point' },
        { num: '13', section: 'Methods', text: 'Time schedule of enrolment, interventions, assessments, and visits (SPIRIT figure)' },
        { num: '14', section: 'Methods', text: 'Sample size (number of participants or observations, number of events) and its justification' },
        { num: '15', section: 'Methods', text: 'Strategies for achieving adequate participant enrolment' },
        { num: '16a', section: 'Methods', text: 'Method of generating the allocation sequence; type of randomisation, details of any restrictions' },
        { num: '16b', section: 'Methods', text: 'Allocation concealment mechanism and implementation details' },
        { num: '16c', section: 'Methods', text: 'Who will generate the allocation sequence, enrol participants, and assign participants to interventions' },
        { num: '17a', section: 'Methods', text: 'Who will be blinded and how (participants, care providers, outcome assessors, data analysts)' },
        { num: '17b', section: 'Methods', text: 'If blinded, circumstances under which unblinding is permissible and procedure for revealing the allocation' },
        { num: '18a', section: 'Methods', text: 'Plans for data collection and quality assurance (forms, instruments, visits schedule)' },
        { num: '18b', section: 'Methods', text: 'Plans to promote participant retention and complete follow-up, including list of any outcome data to be collected for participants who discontinue or deviate' },
        { num: '19', section: 'Methods', text: 'Plans for data management including data entry, coding, security, and storage' },
        { num: '20a', section: 'Methods', text: 'Statistical methods for analysing primary and secondary outcomes' },
        { num: '20b', section: 'Methods', text: 'Methods for any additional analyses (subgroup, adjusted, sensitivity)' },
        { num: '20c', section: 'Methods', text: 'Definition of analysis population (e.g., ITT, per protocol) and any statistical methods to handle missing data' },
        { num: '21a', section: 'Methods', text: 'Plans for interim analyses and stopping guidelines' },
        { num: '21b', section: 'Methods', text: 'Composition, role, and reporting structure of the data monitoring committee' },
        { num: '22', section: 'Methods', text: 'Plans for communicating important protocol amendments to relevant parties' },
        { num: '23', section: 'Ethics', text: 'Plans for seeking research ethics/IRB approval' },
        { num: '24', section: 'Ethics', text: 'Plans for seeking informed consent, including any provisions for surrogate consent' },
        { num: '25', section: 'Ethics', text: 'Plans for collection, laboratory evaluation, and storage of biological specimens' },
        { num: '26a', section: 'Ethics', text: 'Plans for investigators and sponsor to communicate trial results to participants, healthcare professionals, the public, and other relevant groups' },
        { num: '26b', section: 'Ethics', text: 'Authorship eligibility guidelines and plans for professional writers' },
        { num: '27', section: 'Ethics', text: 'How personal information about potential and enrolled participants will be protected (confidentiality)' },
        { num: '28', section: 'Ethics', text: 'Financial and other competing interests for principal investigators' },
        { num: '29', section: 'Ethics', text: 'Provisions for post-trial care and compensation for those who suffer harm from participation' },
        { num: '30', section: 'Appendices', text: 'Informed consent materials and other related documents given to participants' },
        { num: '31', section: 'Appendices', text: 'Biological specimens: plans for collection, storage, genetic/molecular testing' },
        { num: '32', section: 'Appendices', text: 'Plans for dissemination of findings: publications, data sharing, repositories' },
        { num: '33', section: 'Appendices', text: 'Plans for granting public access to the full protocol, participant-level dataset, and statistical code' }
    ];

    checklists['STARD'] = [
        { num: '1',  section: 'Title / Abstract', text: 'Identification as a study of diagnostic accuracy using at least one measure (sensitivity, specificity, predictive values, or AUC)' },
        { num: '2',  section: 'Abstract', text: 'Structured abstract with study design, methods, results, and conclusions' },
        { num: '3',  section: 'Introduction', text: 'Scientific and clinical background, including the intended use and clinical role of the index test' },
        { num: '4',  section: 'Introduction', text: 'Study objectives and hypotheses' },
        { num: '5',  section: 'Methods', text: 'Whether data collection was planned before the index test and reference standard were performed (prospective study) or after (retrospective study)' },
        { num: '6',  section: 'Methods', text: 'Eligibility criteria' },
        { num: '7',  section: 'Methods', text: 'On what basis potentially eligible participants were identified (symptoms, results from previous tests, inclusion in registry)' },
        { num: '8',  section: 'Methods', text: 'Where and when potentially eligible participants were identified (setting, location and dates)' },
        { num: '9',  section: 'Methods', text: 'Whether participants formed a consecutive, random, or convenience series' },
        { num: '10a', section: 'Methods', text: 'Index test, in sufficient detail to allow replication' },
        { num: '10b', section: 'Methods', text: 'Reference standard, in sufficient detail to allow replication' },
        { num: '11', section: 'Methods', text: 'Rationale for choosing the reference standard (if alternatives exist)' },
        { num: '12a', section: 'Methods', text: 'Definition of and rationale for test positivity cut-offs or result categories of the index test, distinguishing pre-specified from exploratory' },
        { num: '12b', section: 'Methods', text: 'Definition of and rationale for test positivity cut-offs or result categories of the reference standard' },
        { num: '13a', section: 'Methods', text: 'Whether clinical information and reference standard results were available to the performers/readers of the index test' },
        { num: '13b', section: 'Methods', text: 'Whether clinical information and index test results were available to the assessors of the reference standard' },
        { num: '14', section: 'Methods', text: 'Methods for estimating or comparing measures of diagnostic accuracy' },
        { num: '15', section: 'Methods', text: 'How indeterminate index test or reference standard results were handled' },
        { num: '16', section: 'Methods', text: 'How missing data on the index test and reference standard were handled' },
        { num: '17', section: 'Methods', text: 'Any analyses of variability in diagnostic accuracy, distinguishing pre-specified from exploratory' },
        { num: '18', section: 'Methods', text: 'Intended sample size and how it was determined' },
        { num: '19', section: 'Results', text: 'Flow of participants, using a diagram' },
        { num: '20', section: 'Results', text: 'Baseline demographic and clinical characteristics of participants' },
        { num: '21', section: 'Results', text: 'Distribution of severity of disease in those with the target condition; other diagnoses in those without' },
        { num: '22', section: 'Results', text: 'A cross tabulation of the index test results by the results of the reference standard' },
        { num: '23', section: 'Results', text: 'Estimates of diagnostic accuracy and their precision (e.g., 95% CI)' },
        { num: '24', section: 'Results', text: 'Any adverse events from performing the index test or the reference standard' },
        { num: '25', section: 'Discussion', text: 'Study limitations including sources of potential bias, statistical uncertainty, and generalisability' },
        { num: '26', section: 'Discussion', text: 'Implications for practice, including the intended use and clinical role of the index test' },
        { num: '27', section: 'Other', text: 'Registration number and name of registry' },
        { num: '28', section: 'Other', text: 'Where the full study protocol can be accessed' },
        { num: '29', section: 'Other', text: 'Sources of funding and other support; role of funders' },
        { num: '30', section: 'Other', text: 'Conflicts of interest' }
    ];

    checklists['TRIPOD'] = [
        { num: '1',  section: 'Title', text: 'Identify the study as developing and/or validating a multivariable prediction model, the target population, and the outcome' },
        { num: '2',  section: 'Abstract', text: 'Provide a summary of objectives, study design, setting, participants, sample size, predictors, outcome, statistical analysis, results, and conclusions' },
        { num: '3a', section: 'Introduction', text: 'Explain the medical context and rationale for developing or validating the prediction model' },
        { num: '3b', section: 'Introduction', text: 'Specify the objectives, including whether the study describes development or validation of the model or both' },
        { num: '4a', section: 'Methods', text: 'Describe the study design or source of data separately for development and validation data sets' },
        { num: '4b', section: 'Methods', text: 'Specify the key study dates, including start of accrual, end of accrual, and end of follow-up' },
        { num: '5a', section: 'Methods', text: 'Specify key elements of the study setting including number and location of centres' },
        { num: '5b', section: 'Methods', text: 'Describe eligibility criteria for participants' },
        { num: '5c', section: 'Methods', text: 'Give details of treatments received, if relevant' },
        { num: '6a', section: 'Methods', text: 'Clearly define the outcome that is predicted by the prediction model including how and when assessed' },
        { num: '6b', section: 'Methods', text: 'Report any actions to blind assessment of the outcome to be predicted' },
        { num: '7a', section: 'Methods', text: 'Clearly define all predictors used in developing the model, including how and when they were measured' },
        { num: '7b', section: 'Methods', text: 'Report any actions to blind assessment of predictors for the outcome and other predictors' },
        { num: '8',  section: 'Methods', text: 'Explain how the study size was arrived at' },
        { num: '9',  section: 'Methods', text: 'Describe how missing data were handled with details of any imputation method' },
        { num: '10a', section: 'Methods', text: 'Describe how predictors were handled in the analyses' },
        { num: '10b', section: 'Methods', text: 'Specify type of model, all model-building procedures, and method for internal validation' },
        { num: '10c', section: 'Methods', text: 'For validation, describe how the predictions were calculated' },
        { num: '10d', section: 'Methods', text: 'Specify all measures used to assess model performance and, if relevant, to compare multiple models' },
        { num: '11', section: 'Methods', text: 'Provide details on how risk groups were created, if done' },
        { num: '12', section: 'Methods', text: 'For validation, identify any differences from the development data in setting, eligibility criteria, outcome, and predictors' },
        { num: '13a', section: 'Results', text: 'Describe the flow of participants, including the number of participants and outcome events in each analysis' },
        { num: '13b', section: 'Results', text: 'Describe the characteristics of the participants, including the number with missing data for predictors and outcome' },
        { num: '14a', section: 'Results', text: 'Specify the number of participants and outcome events in each analysis' },
        { num: '14b', section: 'Results', text: 'If done, report the unadjusted association between each candidate predictor and outcome' },
        { num: '15a', section: 'Results', text: 'Present the full prediction model to allow predictions for individuals' },
        { num: '15b', section: 'Results', text: 'Explain how to use the prediction model' },
        { num: '16', section: 'Results', text: 'Report performance measures (with CIs) for the prediction model' },
        { num: '17', section: 'Results', text: 'If done, report the results from any model updating' },
        { num: '18', section: 'Discussion', text: 'Discuss any limitations of the study (data source, outcome, predictors)' },
        { num: '19a', section: 'Discussion', text: 'For validation, discuss the results with reference to performance in the development data, and any other validation data' },
        { num: '19b', section: 'Discussion', text: 'Give an overall interpretation of the results considering objectives, limitations, and results from similar studies' },
        { num: '20', section: 'Discussion', text: 'Discuss the potential clinical use of the model and implications for future research' },
        { num: '21', section: 'Other', text: 'Provide information about the availability of supplementary resources (data, analytic code, prediction model)' },
        { num: '22', section: 'Other', text: 'Give the source of funding and the role of the funders' }
    ];

    checklists['CARE'] = [
        { num: '1',  section: 'Title', text: 'The words "case report" should appear in the title along with the area of focus' },
        { num: '2',  section: 'Keywords', text: 'Two to five keywords that identify the case' },
        { num: '3a', section: 'Abstract', text: 'Introduction: What is unique about this case? What does it add to the medical literature?' },
        { num: '3b', section: 'Abstract', text: 'Main symptoms, important clinical findings, main diagnoses, interventions, outcomes' },
        { num: '3c', section: 'Abstract', text: 'Conclusion: What are the main take-away lessons from this case?' },
        { num: '4',  section: 'Introduction', text: 'Brief background summary of the case referencing relevant medical literature' },
        { num: '5a', section: 'Patient Information', text: 'De-identified patient demographics' },
        { num: '5b', section: 'Patient Information', text: 'Main symptoms of the patient (chief complaints)' },
        { num: '5c', section: 'Patient Information', text: 'Medical, family, and psychosocial history including diet, lifestyle, genetic information' },
        { num: '5d', section: 'Patient Information', text: 'Relevant past interventions and their outcomes' },
        { num: '6',  section: 'Clinical Findings', text: 'Describe the relevant physical examination (PE) findings' },
        { num: '7',  section: 'Timeline', text: 'Depict important dates and times in this case as a table or figure' },
        { num: '8a', section: 'Diagnostic Assessment', text: 'Diagnostic methods (PE, laboratory testing, imaging, questionnaires)' },
        { num: '8b', section: 'Diagnostic Assessment', text: 'Diagnostic challenges (e.g., financial, language/cultural)' },
        { num: '8c', section: 'Diagnostic Assessment', text: 'Diagnostic reasoning including other diagnoses considered' },
        { num: '8d', section: 'Diagnostic Assessment', text: 'Prognostic characteristics where applicable' },
        { num: '9a', section: 'Therapeutic Intervention', text: 'Types of intervention (pharmacologic, surgical, preventive, self-care)' },
        { num: '9b', section: 'Therapeutic Intervention', text: 'Administration of intervention (dosage, strength, duration)' },
        { num: '9c', section: 'Therapeutic Intervention', text: 'Changes in therapeutic interventions with rationale' },
        { num: '10a', section: 'Follow-up and Outcomes', text: 'Clinician and patient-assessed outcomes when appropriate' },
        { num: '10b', section: 'Follow-up and Outcomes', text: 'Important follow-up diagnostic and other test results' },
        { num: '10c', section: 'Follow-up and Outcomes', text: 'Intervention adherence and tolerability (and how assessed)' },
        { num: '10d', section: 'Follow-up and Outcomes', text: 'Adverse and unanticipated events' },
        { num: '11', section: 'Discussion', text: 'Strengths and limitations in the management of this case' },
        { num: '12', section: 'Discussion', text: 'Discussion of the relevant medical literature with references' },
        { num: '13', section: 'Discussion', text: 'The rationale for conclusions (including assessment of possible causes)' },
        { num: '14', section: 'Discussion', text: 'The primary take-away lessons of this case report' },
        { num: '15', section: 'Patient Perspective', text: 'When appropriate, the patient should share their perspective on the treatments received' },
        { num: '16', section: 'Informed Consent', text: 'The patient should give informed consent for the publication of the report' }
    ];

    checklists['CHEERS'] = [
        { num: '1',  section: 'Title', text: 'Identify the study as an economic evaluation and specify the interventions being compared' },
        { num: '2',  section: 'Abstract', text: 'Provide a structured summary including objectives, perspective, setting, methods, results, and conclusions' },
        { num: '3',  section: 'Introduction', text: 'Provide an explicit statement of the broader context for the study and present the study question with sub-questions' },
        { num: '4',  section: 'Methods', text: 'Indicate the health decision problem and its overall context' },
        { num: '5',  section: 'Methods', text: 'Describe the characteristics of the base-case population (who is affected by the intervention)' },
        { num: '6',  section: 'Methods', text: 'State the location, relevant features, and why chosen' },
        { num: '7',  section: 'Methods', text: 'Describe comparators with rationale' },
        { num: '8',  section: 'Methods', text: 'State the perspective(s) adopted and justify' },
        { num: '9',  section: 'Methods', text: 'Describe the time horizon for costs and outcomes and the discount rate' },
        { num: '10', section: 'Methods', text: 'Describe how health outcomes were measured or valued' },
        { num: '11', section: 'Methods', text: 'Describe approaches used to estimate resource use and costs' },
        { num: '12', section: 'Methods', text: 'Describe currency, price date, and conversion' },
        { num: '13', section: 'Methods', text: 'Describe and justify the model structure, diagram if applicable' },
        { num: '14', section: 'Methods', text: 'Describe all analytical methods supporting the evaluation; describe approaches for uncertainty analysis' },
        { num: '15', section: 'Results', text: 'Report the values, ranges, references, and probability distributions for all parameters' },
        { num: '16', section: 'Results', text: 'Report mean values for the main categories of costs and outcomes and summarize in a cost-effectiveness table' },
        { num: '17', section: 'Results', text: 'Describe the effects of uncertainty; present sensitivity analyses, scenario analyses, etc.' },
        { num: '18', section: 'Discussion', text: 'Summarise key findings and describe how they support the conclusions reached. Discuss limitations and generalisability' },
        { num: '19', section: 'Other', text: 'Describe how the study was funded and the role of the funder; report conflicts of interest' }
    ];

    checklists['ARRIVE'] = [
        { num: '1',  section: 'Essential', text: 'Study design: Provide details of the study design including the type of experimental design and specify the experimental unit' },
        { num: '2',  section: 'Essential', text: 'Sample size: Specify the total number of animals used in each experiment, and the number of animals in each experimental group. Explain how the sample size was decided' },
        { num: '3',  section: 'Essential', text: 'Inclusion and exclusion criteria: Describe any a priori criteria used for including and excluding animals (or experimental units), and data points' },
        { num: '4',  section: 'Essential', text: 'Randomisation: State whether randomisation was used to allocate experimental units to control and treatment groups. If done, describe the method' },
        { num: '5',  section: 'Essential', text: 'Blinding: Describe who was blinded to the group allocation and outcome assessment, and how' },
        { num: '6',  section: 'Essential', text: 'Outcome measures: Clearly define all outcome measures assessed (primary and secondary)' },
        { num: '7',  section: 'Essential', text: 'Statistical methods: Provide details of the statistical methods used for each analysis, methods for assessing model assumptions' },
        { num: '8',  section: 'Essential', text: 'Experimental animals: Provide species-specific details such as species, strain, sex, developmental stage, weight, and source' },
        { num: '9',  section: 'Essential', text: 'Experimental procedures: Describe each procedure, treatment, and intervention (including route of delivery, frequency, anaesthesia, analgesia, and surgical procedure)' },
        { num: '10', section: 'Essential', text: 'Results: Report results for each outcome measure with a measure of precision (e.g., SEM or CI). For hypothesis testing, report exact p values' },
        { num: '11', section: 'Recommended', text: 'Abstract: Provide an accurate summary of the research objectives, animal species, key methods, principal findings, and the study interpretation' },
        { num: '12', section: 'Recommended', text: 'Background: Include sufficient scientific background to understand the rationale and context for the study, and explain the experimental approach' },
        { num: '13', section: 'Recommended', text: 'Objectives: Clearly describe the research question(s) that the study addresses. Indicate the primary objective(s) and any pre-specified hypotheses' },
        { num: '14', section: 'Recommended', text: 'Ethical statement: Provide the name of the ethical review committee or body that approved the study and the licence/protocol number' },
        { num: '15', section: 'Recommended', text: 'Housing and husbandry: Provide details of housing and husbandry conditions such as cage type, bedding, food and water access, light/dark cycle, temperature, and enrichment' },
        { num: '16', section: 'Recommended', text: 'Animal care and monitoring: Describe any interventions or steps taken to reduce severity of experimental procedures; note any humane endpoints' },
        { num: '17', section: 'Recommended', text: 'Interpretation/scientific implications: Interpret the results, taking into account the study objectives and hypotheses, current evidence, and limitations' },
        { num: '18', section: 'Recommended', text: 'Generalisability/translation: Comment on whether the findings can be generalised to other species or experimental conditions (external validity) and potential translational implications' },
        { num: '19', section: 'Recommended', text: 'Protocol registration: Provide a link to the protocol if registered' },
        { num: '20', section: 'Recommended', text: 'Data access: Include a statement describing if and where study data can be accessed' },
        { num: '21', section: 'Recommended', text: 'Declaration of interests: Declare all potential competing or financial interests that could be perceived to influence the research' }
    ];

    checklists['AGREE-II'] = [
        { num: '1',  section: 'Scope and Purpose', text: 'The overall objective(s) of the guideline is (are) specifically described' },
        { num: '2',  section: 'Scope and Purpose', text: 'The health question(s) covered by the guideline is (are) specifically described' },
        { num: '3',  section: 'Scope and Purpose', text: 'The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described' },
        { num: '4',  section: 'Stakeholder Involvement', text: 'The guideline development group includes individuals from all relevant professional groups' },
        { num: '5',  section: 'Stakeholder Involvement', text: 'The views and preferences of the target population (patients, public, etc.) have been sought' },
        { num: '6',  section: 'Stakeholder Involvement', text: 'The target users of the guideline are clearly defined' },
        { num: '7',  section: 'Rigour of Development', text: 'Systematic methods were used to search for evidence' },
        { num: '8',  section: 'Rigour of Development', text: 'The criteria for selecting the evidence are clearly described' },
        { num: '9',  section: 'Rigour of Development', text: 'The strengths and limitations of the body of evidence are clearly described' },
        { num: '10', section: 'Rigour of Development', text: 'The methods for formulating the recommendations are clearly described' },
        { num: '11', section: 'Rigour of Development', text: 'The health benefits, side effects, and risks have been considered in formulating the recommendations' },
        { num: '12', section: 'Rigour of Development', text: 'There is an explicit link between the recommendations and the supporting evidence' },
        { num: '13', section: 'Rigour of Development', text: 'The guideline has been externally reviewed by experts prior to its publication' },
        { num: '14', section: 'Rigour of Development', text: 'A procedure for updating the guideline is provided' },
        { num: '15', section: 'Clarity of Presentation', text: 'The recommendations are specific and unambiguous' },
        { num: '16', section: 'Clarity of Presentation', text: 'The different options for management of the condition or health issue are clearly presented' },
        { num: '17', section: 'Clarity of Presentation', text: 'Key recommendations are easily identifiable' },
        { num: '18', section: 'Applicability', text: 'The guideline describes facilitators and barriers to its application' },
        { num: '19', section: 'Applicability', text: 'The guideline provides advice and/or tools on how the recommendations can be put into practice' },
        { num: '20', section: 'Applicability', text: 'The potential resource implications of applying the recommendations have been considered' },
        { num: '21', section: 'Applicability', text: 'The guideline presents monitoring and/or auditing criteria' },
        { num: '22', section: 'Editorial Independence', text: 'The views of the funding body have not influenced the content of the guideline' },
        { num: '23', section: 'Editorial Independence', text: 'Competing interests of guideline development group members have been recorded and addressed' }
    ];

    checklists['RECORD'] = [
        { num: 'R1',  section: 'Title / Abstract', text: 'The type of data used should be specified in the title or abstract. When possible, the name of the databases used should be included' },
        { num: 'R2',  section: 'Title / Abstract', text: 'The geographic region and time frame should be specified' },
        { num: 'R3',  section: 'Methods', text: 'The population of interest and the database used to create the study population should be described in detail' },
        { num: 'R4',  section: 'Methods', text: 'Any validation studies of the codes or algorithms used to identify participants should be referenced' },
        { num: 'R5',  section: 'Methods', text: 'Complete list of codes and algorithms used to classify exposures, outcomes, confounders, and effect modifiers' },
        { num: 'R6',  section: 'Methods', text: 'State the methods for data cleaning; describe if data linkage was performed' },
        { num: 'R7',  section: 'Methods', text: 'If applicable, describe the methods of study size calculation' },
        { num: 'R8',  section: 'Results', text: 'Describe the completeness of data, including percentage of missing and/or unavailable data' },
        { num: 'R9',  section: 'Results', text: 'Authors should provide information on who had access to the data, data security procedures, and any audit processes' },
        { num: 'R10', section: 'Discussion', text: 'Discuss the implications of using data that were not created for the purpose of the study' },
        { num: 'R11', section: 'Other', text: 'State whether the study included person-level, institutional-level, or other data' },
        { num: 'R12', section: 'Other', text: 'Authors should provide information on data access and cleaning methods' },
        { num: 'R13', section: 'Other', text: 'Authors should describe ethical approval requirements and the involvement of patients/public in the research' }
    ];

    checklists['MOOSE'] = [
        { num: '1',  section: 'Reporting of Background', text: 'Problem definition' },
        { num: '2',  section: 'Reporting of Background', text: 'Hypothesis statement' },
        { num: '3',  section: 'Reporting of Background', text: 'Description of study outcome(s)' },
        { num: '4',  section: 'Reporting of Background', text: 'Type of exposure or intervention used' },
        { num: '5',  section: 'Reporting of Background', text: 'Type of study designs used' },
        { num: '6',  section: 'Reporting of Background', text: 'Study population' },
        { num: '7',  section: 'Reporting of Search Strategy', text: 'Qualifications of searchers (e.g., librarians and investigators)' },
        { num: '8',  section: 'Reporting of Search Strategy', text: 'Search strategy, including time period included in the synthesis and keywords' },
        { num: '9',  section: 'Reporting of Search Strategy', text: 'Effort to include all available studies, including contact with authors' },
        { num: '10', section: 'Reporting of Search Strategy', text: 'Databases and registries searched' },
        { num: '11', section: 'Reporting of Search Strategy', text: 'Search software used, name and version, including special features used' },
        { num: '12', section: 'Reporting of Search Strategy', text: 'Use of hand searching (e.g., reference lists of obtained articles)' },
        { num: '13', section: 'Reporting of Search Strategy', text: 'List of citations located and those excluded, including justification' },
        { num: '14', section: 'Reporting of Search Strategy', text: 'Method of addressing articles published in languages other than English' },
        { num: '15', section: 'Reporting of Search Strategy', text: 'Method of handling abstracts and unpublished studies' },
        { num: '16', section: 'Reporting of Search Strategy', text: 'Description of any contact with authors' },
        { num: '17', section: 'Reporting of Methods', text: 'Description of relevance or appropriateness of studies assembled for assessing the hypothesis' },
        { num: '18', section: 'Reporting of Methods', text: 'Rationale for the selection and coding of data (e.g., sound clinical principles or convenience)' },
        { num: '19', section: 'Reporting of Methods', text: 'Documentation of how data were classified and coded (e.g., multiple raters, blinding, inter-rater reliability)' },
        { num: '20', section: 'Reporting of Methods', text: 'Assessment of confounding (e.g., comparability of cases/controls in studies where appropriate)' },
        { num: '21', section: 'Reporting of Methods', text: 'Assessment of study quality, including blinding of quality assessors; stratification or regression on possible predictors of study results' },
        { num: '22', section: 'Reporting of Methods', text: 'Assessment of heterogeneity' },
        { num: '23', section: 'Reporting of Methods', text: 'Description of statistical methods in sufficient detail to be replicated' },
        { num: '24', section: 'Reporting of Methods', text: 'Provision of appropriate tables and graphics' },
        { num: '25', section: 'Reporting of Results', text: 'Graphic summarizing individual study estimates and overall estimate' },
        { num: '26', section: 'Reporting of Results', text: 'Table giving descriptive information for each study included' },
        { num: '27', section: 'Reporting of Results', text: 'Results of sensitivity testing (e.g., subgroup analysis)' },
        { num: '28', section: 'Reporting of Results', text: 'Indication of statistical uncertainty of findings' },
        { num: '29', section: 'Reporting of Discussion', text: 'Quantitative assessment of bias (e.g., publication bias)' },
        { num: '30', section: 'Reporting of Discussion', text: 'Justification for exclusion (e.g., exclusion of non-English-language citations)' },
        { num: '31', section: 'Reporting of Discussion', text: 'Assessment of quality of included studies' },
        { num: '32', section: 'Reporting of Conclusions', text: 'Consideration of alternative explanations for observed results' },
        { num: '33', section: 'Reporting of Conclusions', text: 'Generalization of the conclusions' },
        { num: '34', section: 'Reporting of Conclusions', text: 'Guidelines for future research' },
        { num: '35', section: 'Reporting of Conclusions', text: 'Disclosure of funding source' }
    ];

    /* ------------------------------------------------------------------ */
    /*  Render                                                             */
    /* ------------------------------------------------------------------ */
    function render(container) {
        var html = App.createModuleLayout(
            'Reporting Guidelines Hub',
            'Interactive checklists for major research reporting guidelines. Select a guideline, track your progress, and export completed checklists.'
        );

        // Learn & Reference section
        html += '<div class="card" style="background: var(--bg-secondary); border-left: 4px solid var(--accent-color);">';
        html += '<div class="card-title" style="cursor:pointer;" onclick="this.parentElement.querySelector(\'.learn-body\').classList.toggle(\'hidden\')">&#128218; Learn &amp; Reference <span style="font-size:0.8em; color: var(--text-muted);">(click to expand)</span></div>';
        html += '<div class="learn-body hidden">';

        html += '<div style="margin-bottom:1.2rem;">';
        html += '<div style="font-weight:700;margin-bottom:0.4rem;color:var(--accent);">When to Use Which Guideline</div>';
        html += '<ul style="margin:0;padding-left:1.5rem;font-size:0.9rem;line-height:1.7;">';
        html += '<li><strong>CONSORT</strong> &rarr; RCTs</li>';
        html += '<li><strong>STROBE</strong> &rarr; Observational studies</li>';
        html += '<li><strong>PRISMA</strong> &rarr; Systematic reviews / meta-analyses</li>';
        html += '<li><strong>SPIRIT</strong> &rarr; Trial protocols</li>';
        html += '<li><strong>TRIPOD</strong> &rarr; Prediction models</li>';
        html += '<li><strong>ARRIVE</strong> &rarr; Animal studies</li>';
        html += '<li><strong>STARD</strong> &rarr; Diagnostic accuracy</li>';
        html += '</ul>';
        html += '</div>';

        html += '<div style="margin-bottom:1.2rem;">';
        html += '<div style="font-weight:700;margin-bottom:0.4rem;color:var(--accent);">Key Principles</div>';
        html += '<ul style="margin:0;padding-left:1.5rem;font-size:0.9rem;line-height:1.7;">';
        html += '<li>Complete reporting improves reproducibility.</li>';
        html += '<li>Checklists &ne; quality assessment.</li>';
        html += '<li>All items should be addressed (even if &ldquo;not applicable&rdquo;).</li>';
        html += '<li>Page/section numbers should be included.</li>';
        html += '</ul>';
        html += '</div>';

        html += '<div style="margin-bottom:1.2rem;">';
        html += '<div style="font-weight:700;margin-bottom:0.4rem;color:var(--accent);">Common Pitfalls</div>';
        html += '<ul style="margin:0;padding-left:1.5rem;font-size:0.9rem;line-height:1.7;">';
        html += '<li>Treating checklists as quality scores</li>';
        html += '<li>Omitting negative/null results</li>';
        html += '<li>Inadequate flow diagrams</li>';
        html += '<li>Not registering protocols prospectively</li>';
        html += '</ul>';
        html += '</div>';

        html += '<div>';
        html += '<div style="font-weight:700;margin-bottom:0.4rem;color:var(--accent);">References</div>';
        html += '<ul style="margin:0;padding-left:1.5rem;font-size:0.85rem;line-height:1.7;">';
        html += '<li>EQUATOR Network (equator-network.org)</li>';
        html += '<li>Moher D et al. CONSORT 2010</li>';
        html += '<li>von Elm E et al. STROBE</li>';
        html += '<li>Page MJ et al. PRISMA 2020</li>';
        html += '</ul>';
        html += '</div>';

        html += '</div></div>';

        /* Card 1: Guideline Selector */
        html += '<div class="card">';
        html += '<div class="card-title">Select Reporting Guideline</div>';
        html += '<div class="form-row form-row--2">';
        html += '<div class="form-group">';
        html += '<label class="form-label">Guideline</label>';
        html += '<select class="form-select" id="rg-guideline-select" onchange="ReportingGuide.selectGuideline()">';
        var keys = Object.keys(guidelines);
        for (var i = 0; i < keys.length; i++) {
            var k = keys[i];
            var sel = (k === currentGuideline) ? ' selected' : '';
            html += '<option value="' + k + '"' + sel + '>' + guidelines[k].name + '</option>';
        }
        html += '</select>';
        html += '</div>';
        html += '<div class="form-group">';
        html += '<label class="form-label">When to Use</label>';
        html += '<div class="form-input" id="rg-description" style="background:var(--bg-elevated);min-height:2.2rem;display:flex;align-items:center;font-size:0.9rem;">' + guidelines[currentGuideline].use + '</div>';
        html += '</div>';
        html += '</div>';

        /* Guideline quick-reference table */
        html += '<div class="card-subtitle mt-1">Quick Reference: All Guidelines</div>';
        html += '<div class="table-container">';
        html += '<table class="data-table">';
        html += '<thead><tr><th>Guideline</th><th>Full Name</th><th>Study Type</th><th>Items</th></tr></thead>';
        html += '<tbody>';
        for (var j = 0; j < keys.length; j++) {
            var gk = keys[j];
            var itemCount = checklists[gk] ? checklists[gk].length : '—';
            html += '<tr>';
            html += '<td><strong>' + gk + '</strong></td>';
            html += '<td>' + guidelines[gk].name + '</td>';
            html += '<td>' + guidelines[gk].use + '</td>';
            html += '<td>' + itemCount + '</td>';
            html += '</tr>';
        }
        html += '</tbody></table>';
        html += '</div>';
        html += '</div>';

        /* Card 2: Interactive Checklist */
        html += '<div class="card">';
        html += '<div class="card-title" id="rg-checklist-title">Checklist: ' + guidelines[currentGuideline].name + '</div>';

        /* Progress bar */
        html += '<div style="margin-bottom:1rem;">';
        html += '<div style="display:flex;justify-content:space-between;font-size:0.85rem;margin-bottom:0.3rem;">';
        html += '<span id="rg-progress-text">0 / ' + (checklists[currentGuideline] ? checklists[currentGuideline].length : 0) + ' items completed</span>';
        html += '<span id="rg-progress-pct">0%</span>';
        html += '</div>';
        html += '<div style="height:8px;background:var(--bg-elevated);border-radius:4px;overflow:hidden;">';
        html += '<div id="rg-progress-bar" style="height:100%;width:0%;background:var(--accent);border-radius:4px;transition:width 0.3s;"></div>';
        html += '</div>';
        html += '</div>';

        /* Section filter */
        html += '<div class="form-group">';
        html += '<label class="form-label">Filter by Section</label>';
        html += '<select class="form-select" id="rg-section-filter" onchange="ReportingGuide.filterSection()">';
        html += '<option value="all">All Sections</option>';
        html += '</select>';
        html += '</div>';

        /* Checklist container */
        html += '<div id="rg-checklist-body"></div>';

        /* Buttons */
        html += '<div class="btn-group mt-2">';
        html += '<button class="btn btn-primary" onclick="ReportingGuide.copyChecklist()">Copy Completed Checklist</button>';
        html += '<button class="btn btn-secondary" onclick="ReportingGuide.downloadChecklist()">Download as Text</button>';
        html += '<button class="btn btn-secondary" onclick="ReportingGuide.exportChecklist()">Export Full Checklist</button>';
        html += '<button class="btn btn-secondary" onclick="ReportingGuide.resetChecklist()">Reset</button>';
        html += '</div>';

        html += '</div>'; /* end card 2 */

        App.setTrustedHTML(container, html);
        App.autoSaveInputs(container, MODULE_ID);

        buildChecklist();
    }

    /* ------------------------------------------------------------------ */
    /*  Build checklist items                                              */
    /* ------------------------------------------------------------------ */
    function buildChecklist() {
        var gl = currentGuideline;
        var items = checklists[gl];
        if (!items) {
            var body = document.getElementById('rg-checklist-body');
            if (body) App.setTrustedHTML(body, '<p style="color:var(--text-secondary)">Checklist data not yet available for this guideline.</p>');
            return;
        }

        /* Collect unique sections */
        var sections = [];
        var sectionMap = {};
        for (var i = 0; i < items.length; i++) {
            if (!sectionMap[items[i].section]) {
                sectionMap[items[i].section] = true;
                sections.push(items[i].section);
            }
        }

        /* Populate section filter */
        var filterEl = document.getElementById('rg-section-filter');
        if (filterEl) {
            var fhtml = '<option value="all">All Sections</option>';
            for (var s = 0; s < sections.length; s++) {
                fhtml += '<option value="' + sections[s] + '">' + sections[s] + '</option>';
            }
            App.setTrustedHTML(filterEl, fhtml);
        }

        /* Initialize checklist state for this guideline if not present */
        if (!checklistState[gl]) {
            checklistState[gl] = {};
        }

        /* Build items grouped by section */
        var bodyHtml = '';
        for (var si = 0; si < sections.length; si++) {
            var sec = sections[si];
            bodyHtml += '<div class="rg-section-group" data-section="' + sec + '">';
            bodyHtml += '<div style="font-weight:600;font-size:0.95rem;color:var(--accent);margin:1rem 0 0.5rem;border-bottom:1px solid var(--border);padding-bottom:0.3rem;">' + sec + '</div>';

            for (var ii = 0; ii < items.length; ii++) {
                if (items[ii].section !== sec) continue;
                var item = items[ii];
                var itemKey = gl + '_' + item.num;
                var checked = checklistState[gl][item.num] ? ' checked' : '';

                bodyHtml += '<label style="display:flex;align-items:flex-start;gap:0.5rem;padding:0.4rem 0;cursor:pointer;font-size:0.9rem;">';
                bodyHtml += '<input type="checkbox" id="rg-chk-' + itemKey + '"' + checked + ' onchange="ReportingGuide.toggleItem(\'' + gl + '\',\'' + item.num + '\')" style="margin-top:3px;flex-shrink:0;">';
                bodyHtml += '<span><strong>' + item.num + '.</strong> ' + item.text + '</span>';
                bodyHtml += '</label>';
            }
            bodyHtml += '</div>';
        }

        var body = document.getElementById('rg-checklist-body');
        if (body) App.setTrustedHTML(body, bodyHtml);

        updateProgress();
    }

    /* ------------------------------------------------------------------ */
    /*  Guideline selection                                                */
    /* ------------------------------------------------------------------ */
    function selectGuideline() {
        var sel = document.getElementById('rg-guideline-select');
        if (!sel) return;
        currentGuideline = sel.value;

        var descEl = document.getElementById('rg-description');
        if (descEl) App.setTrustedHTML(descEl, guidelines[currentGuideline].use);

        var titleEl = document.getElementById('rg-checklist-title');
        if (titleEl) App.setTrustedHTML(titleEl, 'Checklist: ' + guidelines[currentGuideline].name);

        buildChecklist();
    }

    /* ------------------------------------------------------------------ */
    /*  Toggle item                                                        */
    /* ------------------------------------------------------------------ */
    function toggleItem(gl, num) {
        if (!checklistState[gl]) checklistState[gl] = {};
        checklistState[gl][num] = !checklistState[gl][num];
        updateProgress();
    }

    /* ------------------------------------------------------------------ */
    /*  Update progress                                                    */
    /* ------------------------------------------------------------------ */
    function updateProgress() {
        var gl = currentGuideline;
        var items = checklists[gl];
        if (!items) return;

        var total = items.length;
        var done = 0;
        for (var i = 0; i < items.length; i++) {
            if (checklistState[gl] && checklistState[gl][items[i].num]) done++;
        }
        var pct = total > 0 ? Math.round((done / total) * 100) : 0;

        var textEl = document.getElementById('rg-progress-text');
        if (textEl) App.setTrustedHTML(textEl, done + ' / ' + total + ' items completed');

        var pctEl = document.getElementById('rg-progress-pct');
        if (pctEl) App.setTrustedHTML(pctEl, pct + '%');

        var barEl = document.getElementById('rg-progress-bar');
        if (barEl) barEl.style.width = pct + '%';
    }

    /* ------------------------------------------------------------------ */
    /*  Filter by section                                                  */
    /* ------------------------------------------------------------------ */
    function filterSection() {
        var filter = document.getElementById('rg-section-filter');
        if (!filter) return;
        var val = filter.value;

        var groups = document.querySelectorAll('.rg-section-group');
        for (var i = 0; i < groups.length; i++) {
            if (val === 'all' || groups[i].getAttribute('data-section') === val) {
                groups[i].style.display = '';
            } else {
                groups[i].style.display = 'none';
            }
        }
    }

    /* ------------------------------------------------------------------ */
    /*  Generate checklist text                                            */
    /* ------------------------------------------------------------------ */
    function generateChecklistText(completedOnly) {
        var gl = currentGuideline;
        var items = checklists[gl];
        if (!items) return '';

        var lines = [];
        lines.push(guidelines[gl].name + ' Checklist');
        lines.push('='.repeat(40));
        lines.push('');

        var lastSection = '';
        for (var i = 0; i < items.length; i++) {
            var item = items[i];
            var done = checklistState[gl] && checklistState[gl][item.num];

            if (completedOnly && !done) continue;

            if (item.section !== lastSection) {
                if (lastSection !== '') lines.push('');
                lines.push('--- ' + item.section + ' ---');
                lastSection = item.section;
            }

            var mark = done ? '[X]' : '[ ]';
            lines.push(mark + ' ' + item.num + '. ' + item.text);
        }

        var total = items.length;
        var doneCount = 0;
        for (var j = 0; j < items.length; j++) {
            if (checklistState[gl] && checklistState[gl][items[j].num]) doneCount++;
        }
        lines.push('');
        lines.push('Progress: ' + doneCount + '/' + total + ' (' + Math.round((doneCount / total) * 100) + '%)');
        lines.push('Generated: ' + new Date().toLocaleDateString());

        return lines.join('\n');
    }

    /* ------------------------------------------------------------------ */
    /*  Export / Copy / Download                                           */
    /* ------------------------------------------------------------------ */
    function copyChecklist() {
        var text = generateChecklistText(true);
        if (!text || text.split('\n').length < 6) {
            text = generateChecklistText(false);
        }
        Export.copyText(text);
    }

    function downloadChecklist() {
        var text = generateChecklistText(false);
        var blob = new Blob([text], { type: 'text/plain' });
        var url = URL.createObjectURL(blob);
        var a = document.createElement('a');
        a.href = url;
        a.download = currentGuideline.toLowerCase() + '-checklist.txt';
        document.body.appendChild(a);
        a.click();
        document.body.removeChild(a);
        URL.revokeObjectURL(url);
    }

    function exportChecklist() {
        var text = generateChecklistText(false);
        Export.copyText(text);
    }

    function resetChecklist() {
        checklistState[currentGuideline] = {};
        buildChecklist();
    }

    /* ------------------------------------------------------------------ */
    /*  Register                                                           */
    /* ------------------------------------------------------------------ */
    App.registerModule(MODULE_ID, { render: render });
    window.ReportingGuide = {
        selectGuideline: selectGuideline,
        toggleItem: toggleItem,
        filterSection: filterSection,
        copyChecklist: copyChecklist,
        downloadChecklist: downloadChecklist,
        exportChecklist: exportChecklist,
        resetChecklist: resetChecklist
    };
})();
